Dr. Sharvil Patel is the Managing Director of Cadila Healthcare Ltd., one of the leading global healthcare providers and the 4th largest pharmaceutical company in India and officiates as the Chairman on the Board of Zydus Wellness Ltd. (ZWL), the listed entity of the Zydus group that spearheads the group’s presence in the fast growing consumer healthcare market. ZWL recently acquired Heinz India’s business including the brands Complan, Glucon D, Nycil and Sampriti Ghee.
With a specialisation in Chemical and Pharmaceutical Sciences from the University of Sunderland, UK and a doctorate also from the same university for his research work in Breast Cancer at Johns Hopkins, Bayview Medical Centre, USA.
Dr. Sharvil Patel spearheads organization-wide initiatives including Quest - the quality excellence programme and champions innovation in bringing new products to the market, new technologies, new patient-centric approaches and differentiated strategies to create a future-ready organisation.
He was conferred the ‘40 Under 40 Most Influential Asians’ Award by the Asian Business & Social Forum 2018 (ABSF) and the Young Business Leader ’40 under Forty’ Award by ET Now in 2017.